Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.
2.

Role of the androgen receptor axis in prostate cancer.

Culig Z.

Urology. 2003 Nov;62(5 Suppl 1):21-6. Review.

PMID:
14607214
3.

Prostate specific antigen gene regulation by androgen receptor.

Kim J, Coetzee GA.

J Cell Biochem. 2004 Oct 1;93(2):233-41. Review.

PMID:
15368351
4.

Prostate cancer: molecular biology of early progression to androgen independence.

Sadar MD, Hussain M, Bruchovsky N.

Endocr Relat Cancer. 1999 Dec;6(4):487-502. Review.

5.

Expression and function of androgen receptor coactivators in prostate cancer.

Culig Z, Comuzzi B, Steiner H, Bartsch G, Hobisch A.

J Steroid Biochem Mol Biol. 2004 Nov;92(4):265-71. Epub 2004 Dec 19. Review.

PMID:
15663989
6.

Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence.

Taplin ME, Balk SP.

J Cell Biochem. 2004 Feb 15;91(3):483-90. Review.

PMID:
14755679
7.

Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.

Carruba G.

J Cell Biochem. 2007 Nov 1;102(4):899-911. Review.

PMID:
17786930
8.

Androgen-regulated gene expression in prostate cancer.

Trapman J, Cleutjens KB.

Semin Cancer Biol. 1997 Feb;8(1):29-36. Review.

PMID:
9299579
9.

Interleukin-6 and prostate cancer progression.

Smith PC, Hobisch A, Lin DL, Culig Z, Keller ET.

Cytokine Growth Factor Rev. 2001 Mar;12(1):33-40. Review.

PMID:
11312117
10.

Androgens, antiandrogens and androgen receptor abnormalities.

Kuil CW, Brinkmann AO.

Eur Urol. 1996;29 Suppl 2:78-82. Review.

PMID:
8717468
11.

Regulation of androgen receptor signaling in prostate cancer.

Dehm SM, Tindall DJ.

Expert Rev Anticancer Ther. 2005 Feb;5(1):63-74. Review.

PMID:
15757439
12.

[Research on the structure of the PSA promoter and the mechanisms of its expression regulation].

Wang J, Zhou JG, Huang CF.

Yi Chuan. 2004 Sep;26(5):739-44. Review. Chinese.

PMID:
15640095
13.

[Mutations of the androgen receptor gene a possible role in prostate cancer].

Mowszowicz I, Mestayer C.

Bull Cancer. 1997 Feb;84(2):183-8. Review. French.

14.

The control of prostate-specific antigen expression and gene regulation by pharmacological agents.

Dixon SC, Knopf KB, Figg WD.

Pharmacol Rev. 2001 Mar;53(1):73-91. Review.

15.

Signal transduction in prostate cancer progression.

Gioeli D.

Clin Sci (Lond). 2005 Apr;108(4):293-308. Review.

PMID:
15603554
16.

The androgen receptor: structure, mutations, and antiandrogens.

Hirawat S, Budman DR, Kreis W.

Cancer Invest. 2003 Jun;21(3):400-17. Review. Erratum in: Cancer Invest. 2003;21(6):960-2.

PMID:
12901287
17.

The androgen receptor gene and its influence on the development and progression of prostate cancer.

Montgomery JS, Price DK, Figg WD.

J Pathol. 2001 Sep;195(2):138-46. Review.

PMID:
11592091
18.

Expression, structure, and function of androgen receptor in advanced prostatic carcinoma.

Culig Z, Hobisch A, Hittmair A, Peterziel H, Cato AC, Bartsch G, Klocker H.

Prostate. 1998 Apr 1;35(1):63-70. Review.

PMID:
9537601
19.

Androgens, lipogenesis and prostate cancer.

Swinnen JV, Heemers H, van de Sande T, de Schrijver E, Brusselmans K, Heyns W, Verhoeven G.

J Steroid Biochem Mol Biol. 2004 Nov;92(4):273-9. Epub 2004 Dec 19. Review.

PMID:
15663990
20.

The androgen receptor: a potential target for therapy of prostate cancer.

Santos AF, Huang H, Tindall DJ.

Steroids. 2004 Feb;69(2):79-85. Review.

PMID:
15013685

Supplemental Content

Support Center